Clinical trial
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
NCT00311610 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00311610 |
|---|---|
| Title | Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | SN-38 liposome |
| Enrollment | 30 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jun 1, 2010 |
| First posted | Apr 6, 2006 |
| Last update posted | Jun 29, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: